Resistance to fluoroquinolones in Salmonella:: emerging mechanisms and resistance prevention strategies

被引：88

作者：

Giraud, Etienne

Baucheron, Sylvie

Cloeckaert, Axel

机构：

[1] ENVN Chimiotherapie Aquacole & Environm, INRA, UMR, F-44307 Nantes, France

[2] INRA, Ctr Rech Tours, Unit Bioagresseurs Sante Environm, F-37380 Nouzilly, France

来源：

MICROBES AND INFECTION | 2006年 / 8卷 / 07期

关键词：

fluoroquinolones; resistance; Salmonella;

D O I：

10.1016/j.micinf.2005.12.025

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We review the current state of knowledge about the genetic and biochemical mechanisms that mediate quinolone resistance in Salmonella. They include modifications of topoisomerase targets, increased efflux activity and the recently described topoisomerase protection by the plasmid-encoded Qnr protein. We discuss what factors may determine the order of implementation of these various mechanisms in a particular strain, and what strategies could be used to combat resistance, from the inhibition of mutagenesis mechanisms to counteracting, during fluoroquinolone treatment, of resistance mechanisms already set in the infecting strain. (c) 2006 Elsevier SAS. All rights reserved.

引用

收藏

页码：1937 / 1944

页数：8

相关论文

共 71 条

[1] Is it time to change fluoroquinolone breakpoints for Salmonella spp.? [J].

Aarestrup, FM ;

Wiuff, C ;

Molbak, K ;

Threlfall, EJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (02) :827-829

[2] Phenotypic and genotypic characterization of food animal isolates of Salmonella with reduced sensitivity to ciprofloxacin [J].

Allen, KJ ;

Poppe, C .

MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 2002, 8 (04) :375-383

[3] Origins and consequences of antimicrobial-resistant nontyphoidal Salmonella:: Implications for the use of fluoroquinolones in food animals [J].

Angulo, FJ ;

Johnson, KR ;

Tauxe, RV ;

Cohen, ML .

MICROBIAL DRUG RESISTANCE, 2000, 6 (01) :77-83

[4]

[Anonymous], 2000, M7A5 NAT COMM CLIN L, pM7

[5] High-level resistance to fluoroquinolones linked to mutations in gyrA, parC, and parE in Salmonella enterica serovar Schwarzengrund isolates from humans in Taiwan [J].

Baucheron, S ;

Chaslus-Dancla, E ;

Cloeckaert, A ;

Chiu, CH ;

Butaye, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (02) :862-863

[6] AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium DT104 [J].

Baucheron, S ;

Tyler, S ;

Boyd, D ;

Mulvey, MR ;

Chaslus-Dancla, E ;

Cloeckaert, A .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (10) :3729-3735

[7] Role of TolC and parC mutation in high-level fluoroquinolone resistance in Salmonella enterica serotype Typhimurium DT204 [J].

Baucheron, S ;

Chaslus-Dancla, E ;

Cloeckaert, A .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (04) :657-659

[8] The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar typhimurium phage type DT204 [J].

Baucheron, S ;

Imberechts, H ;

Chaslus-Dancla, E ;

Cloeckaert, A .

MICROBIAL DRUG RESISTANCE, 2002, 8 (04) :281-289

[9] Effects on growth of single short courses of fluoroquinolones [J].

Bethell, DB ;

Hien, TT ;

Phi, LT ;

Day, NPJ ;

Vinh, H ;

Duong, NM ;

VanLen, N ;

VanChuong, L ;

White, NJ .

ARCHIVES OF DISEASE IN CHILDHOOD, 1996, 74 (01) :44-46

[10]

Casin I, 2003, EMERG INFECT DIS, V9, P1455

← 1 2 3 4 5 6 7 8 →